You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

induction of remission

Showing 1 - 25 of 8,144
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Microscopic Colitis Trial (Budesonide MMX®, Budesonide controlled ileal release (CR) capsules)

Not yet recruiting
  • Microscopic Colitis
  • Budesonide MMX®
  • Budesonide controlled ileal release (CR) capsules
  • (no location specified)
Jun 13, 2023

Giant Cell Arteritis Trial in Bonn (Methotrexate, Sodium chloride)

Recruiting
  • Giant Cell Arteritis
  • Bonn, Germany
    Medical Clinic and Polyclinic III Internal medicine Oncology, He
Dec 16, 2022

Exclusive Enteral Nutrition, Ulcerative Colitis, Children Trial (exclusive enteral nutrition, regular food)

Not yet recruiting
  • Exclusive Enteral Nutrition
  • +2 more
  • exclusive enteral nutrition
  • regular food
  • (no location specified)
Dec 5, 2022

Lupus Nephritis, Remission, Safety Issues Trial in Nanjing (Methylprednisolone Injectable Suspension, Belimumab Injection,

Recruiting
  • Lupus Nephritis
  • +2 more
  • Methylprednisolone Injectable Suspension
  • +2 more
  • Nanjing, Jiangsu, China
    Jiong Zhang
May 8, 2023

Secondary Acute Myeloid Leukemia Trial in Ann Arbor (Venetoclax, FLAG Protocol)

Not yet recruiting
  • Secondary Acute Myeloid Leukemia
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Mar 22, 2023

Progression Free Survival, Overall Survival, Maintenance Trial (Ixazomib DX/Lenalidomide DX)

Not yet recruiting
  • Progression Free Survival
  • +2 more
  • Ixazomib DX/Lenalidomide DX
  • (no location specified)
Jul 27, 2022

HIV-1-infection Trial in Pathum Wan (VRC07-523LS, PGDM1400LS, N-803)

Not yet recruiting
  • HIV-1-infection
  • VRC07-523LS
  • +7 more
  • Pathum Wan, Bangkok, Thailand
  • +1 more
Mar 8, 2023

Leukemia, MDS Trial in Gainesville (Diet)

Recruiting
  • Leukemia
  • Myelodysplastic Syndromes
  • Diet
  • Gainesville, Florida
    UF Health Cancer Center
Aug 9, 2022

Maintenance of Remission With Pentasa as Ulcerative Colitis

Completed
  • Ulcerative Colitis
  • Zutphen, Netherlands
    Gelre Ziekenhuizen (there may be other sites in this country)
May 16, 2022

Acute Lymphoblastic Leukemia Trial in New York (Ruxolitinib, Dasatinib, Dexamethasone)

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 25, 2022

Crohn's Disease Trial in Worldwide (Modified Exclusive Enteral Nutrition, Crohn's Disease Exclusion Diet, Partial Enteral

Completed
  • Crohn's Disease
  • Modified Exclusive Enteral Nutrition
  • +3 more
  • Edmonton, Canada
  • +6 more
May 29, 2022

Idiopathic Pulmonary Hemosiderosis, Leflunomide Trial in Guangzhou (Leflunomide, Steroid Drug)

Recruiting
  • Idiopathic Pulmonary Hemosiderosis
  • Leflunomide
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital of Sun Yat-sen University
Jun 30, 2023

Interstitial Lung Disease, Scleroderma Trial in Assiut (Rituximab, IL6 inhibitor)

Completed
  • Interstitial Lung Disease
  • Scleroderma
  • Assiut, Yes, Egypt
    Manal Hassanien
Jul 18, 2023

Crohn Disease Trial in Liège (EXL01, Placebo, SoC corticosteroid - Induction Period)

Not yet recruiting
  • Crohn Disease
  • Liège, Belgium
    CHU de Liege
Sep 13, 2022

Ulcerative Colitis Trial in Los Angeles (Vedolizumab, Tofacitinib)

Not yet recruiting
  • Ulcerative Colitis
  • Los Angeles, California
    Cedars Sinai Medical Center
Oct 18, 2023

Acute Myeloid Leukemia Trial in Germany (HAM, LDAC and/or Mitoxantrone)

Completed
  • Acute Myeloid Leukemia
  • HAM
  • LDAC and/or Mitoxantrone
  • Heidelberg, Baden-Wuerttemberg, Germany
  • +17 more
Aug 2, 2022

Axial Spondyloarthritis Trial in Bonheiden, Ghent, Hasselt (Golimumab)

Recruiting
  • Axial Spondyloarthritis
  • Bonheiden, Antwerpen, Belgium
  • +2 more
Nov 30, 2022

Ulcerative Colitis Trial (Intravenous (IV) infusions)

Not yet recruiting
  • Ulcerative Colitis
  • Intravenous (IV) infusions
  • (no location specified)
Mar 14, 2023

Primary CNS Lymphoma Trial in Stuttgart (Experimental Treatment: one course Rituximab/HD-Methotrexate, two courses of MATRix,

Recruiting
  • Primary Central Nervous System Lymphoma
  • Experimental Treatment: one course Rituximab/HD-Methotrexate, two courses of MATRix
  • Control intervention: four courses of MATRix
  • Stuttgart, Baden-Württemberg, Germany
    Klinikum Stuttgart
Feb 15, 2022

Lupus Nephritis Trial in Bucharest (Rituximab, Mycophenolate Mofetil, Cyclophosphamide)

Recruiting
  • Lupus Nephritis
  • Bucharest, Romania
    Fundeni Clinical Institute
Mar 2, 2022

Pouchitis Trial in Hamilton (Fecal microbiota transplantation, Placebos)

Recruiting
  • Pouchitis
  • Fecal microbiota transplantation
  • Placebos
  • Hamilton, Ontario, Canada
    McMaster University
Apr 5, 2022

Leukemia, Myeloid, Acute Trial in Seoul (Idarubicin)

Recruiting
  • Leukemia, Myeloid, Acute
  • Seoul, Korea, Republic of
    Division of Hematology-Oncology, Konkuk University Medical Cente
Apr 8, 2022

Extrathoracic Sarcoidosis Trial in France (Infliximab, Placebo)

Completed
  • Extrathoracic Sarcoidosis
  • Bobigny, France
  • +9 more
Nov 15, 2021

Ulcerative Colitis Trial in Edmonton (Lyophilized fecal microbiota (LFMT), Placebo)

Recruiting
  • Ulcerative Colitis
  • Lyophilized fecal microbiota (LFMT)
  • Placebo
  • Edmonton, Alberta, Canada
    University of Alberta Hospital
Jul 6, 2022

Arthritis, Rheumatoid Trial in Belgium (Etanercept 50 MG/ML, Leflunomide 10 milligram (MG))

Completed
  • Arthritis, Rheumatoid
  • Etanercept 50 MG/ML
  • Leflunomide 10 milligram (MG)
  • Bonheiden, Antwerpen, Belgium
  • +18 more
Jul 4, 2022